Literature DB >> 23275597

Interobserver agreement after pipeline embolization device implantation.

S H Suh1, H J Cloft, G Lanzino, K Woodward, D F Kallmes.   

Abstract

BACKGROUND AND
PURPOSE: Although flow diversion devices are popular in treatment of aneurysms, angiographic assessment with these devices has rarely been verified by interobserver variability study. The purpose of this study was to determine the interobserver agreement of a 3-point grading system for assessing the angiographic outcome after flow diversion therapy of intracranial, saccular aneurysms and to determine factors affecting such agreement.
MATERIALS AND METHODS: After approval by the institutional review board, 5 independent readers assessed pretreatment and follow-up digital subtraction angiograms from 96 patients treated with the Pipeline embolization device by using a 3-point grading system (complete, near-complete, and incomplete occlusion). "Minor discrepancy" was defined as a difference between any 2 readers of 1 grade, that is, complete vs near-complete or near-complete vs incomplete. "Major discrepancy" was defined as a difference between any 2 readers in which 1 reader noted complete occlusion and the other reader noted incomplete occlusion. We performed statistical analysis for the interobserver agreement by using the intraclass correlation coefficient. Subgroup analyses for discrepancy rate and ICC were performed for previously coiled aneurysms.
RESULTS: The interobserver agreement was excellent (ICC, 0.76; 95% CI, 0.69-0.92). Among 96 cases, there was absolute agreement in 74 (77%), of which 67 had unanimous consensus of "complete" occlusion, 2 "near-complete" occlusion, and 5 "incomplete" occlusion. Discordance between any 2 readers was noted in 22 cases (23%), of which 7 (7.3%) revealed a major discrepancy. Subgroup analysis showed that minor discrepancies were more common among patients previously treated with coils vs those not previously treated with coils (37.5% vs 11.2%; P < .05).
CONCLUSIONS: The observer agreement regarding occlusion after PED therapy is excellent. Only a minority of cases demonstrated discrepancy considered as major in this study.

Entities:  

Mesh:

Year:  2012        PMID: 23275597      PMCID: PMC7964565          DOI: 10.3174/ajnr.A3371

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  21 in total

Review 1.  Misguided efforts and future challenges for research on "diagnostic tests".

Authors:  A R Feinstein
Journal:  J Epidemiol Community Health       Date:  2002-05       Impact factor: 3.710

2.  Estimating the proportion of intracranial aneurysms likely to be amenable to treatment with the pipeline embolization device.

Authors:  Waleed Brinjikji; Harry J Cloft; David Fiorella; Giuseppe Lanzino; David F Kallmes
Journal:  J Neurointerv Surg       Date:  2011-12-02       Impact factor: 5.836

3.  Marked decrease in coil and stent utilization following introduction of flow diversion technology.

Authors:  Emanuela Crobeddu; Giuseppe Lanzino; David F Kallmes; Harry J Cloft
Journal:  J Neurointerv Surg       Date:  2012-04-27       Impact factor: 5.836

4.  Flow-diverter silk stent for the treatment of intracranial aneurysms: 1-year follow-up in a multicenter study.

Authors:  J Berge; A Biondi; P Machi; H Brunel; L Pierot; J Gabrillargues; K Kadziolka; X Barreau; V Dousset; A Bonafé
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-02       Impact factor: 3.825

5.  The reliability of measuring physical characteristics of spiculated masses on mammography.

Authors:  M P Sampat; G J Whitman; T W Stephens; L D Broemeling; N A Heger; A C Bovik; M K Markey
Journal:  Br J Radiol       Date:  2006-12       Impact factor: 3.039

6.  Reporting standards for endovascular repair of saccular intracranial cerebral aneurysms.

Authors:  Philip M Meyers; H Christian Schumacher; Randall T Higashida; Colin P Derdeyn; Gary M Nesbit; David Sacks; Lawrence R Wechsler; Joshua B Bederson; Sean D Lavine; Peter Rasmussen
Journal:  J Vasc Interv Radiol       Date:  2009-07       Impact factor: 3.464

Review 7.  Follow-up angiography of intracranial aneurysms treated with endovascular placement of Guglielmi detachable coils.

Authors:  John Thornton; Gerard M Debrun; Victor A Aletich; Qasim Bashir; Fady T Charbel; James Ausman
Journal:  Neurosurgery       Date:  2002-02       Impact factor: 4.654

8.  Observer agreement regarding the necessity of retreatment of previously coiled recurrent cerebral aneurysms.

Authors:  W P Daugherty; A Ehteshami Rad; J B White; P M Meyers; G L Lanzino; H J Cloft; J Gordon; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2011-01-20       Impact factor: 3.825

9.  Endovascular treatment of ophthalmic segment aneurysms with Guglielmi detachable coils.

Authors:  D Roy; J Raymond; A Bouthillier; M W Bojanowski; R Moumdjian; G L'Espérance
Journal:  AJNR Am J Neuroradiol       Date:  1997-08       Impact factor: 3.825

10.  Observer agreement in the assessment of endovascular aneurysm therapy and aneurysm recurrence.

Authors:  H J Cloft; T Kaufmann; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2007-03       Impact factor: 3.825

View more
  3 in total

1.  Comparison of the flow diverter and stent-assisted coiling in large and giant aneurysms: safety and efficacy based on a propensity score-matched analysis.

Authors:  Yongxin Zhang; Yu Zhou; Pengfei Yang; Jianmin Liu; Yi Xu; Bo Hong; Wenyuan Zhao; Qi Chen; Qing-Hai Huang
Journal:  Eur Radiol       Date:  2015-10-15       Impact factor: 5.315

2.  Evaluation of the Angiographic Grading Scale in Aneurysms Treated with the WEB Device in 80 Rabbits: Correlation with Histologic Evaluation.

Authors:  A Rouchaud; W Brinjikji; Y-H Ding; D Dai; Y Q Zhu; H J Cloft; D F Kallmes; R Kadirvel
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-24       Impact factor: 3.825

3.  A Novel Flow Diverter (Tubridge) for the Treatment of Recurrent Aneurysms: A Single-Center Experience.

Authors:  Yongxin Zhang; Qing-Hai Huang; Yibin Fang; Pengfei Yang; Yi Xu; Bo Hong; Jianmin Liu
Journal:  Korean J Radiol       Date:  2017-07-17       Impact factor: 3.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.